Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Recombinant human soluble thrombomodulin counteracts capillary leakage associated with engraftment syndrome.

Literature DB >> 20603623

Recombinant human soluble thrombomodulin counteracts capillary leakage associated with engraftment syndrome.

T Ikezoe, A Takeuchi, A Taniguchi, K Togitani, A Yokoyama.

Abstract

Entities: Gene Species

Mesh：

Substances：

Year: 2010 PMID： 20603623 DOI： 10.1038/bmt.2010.158

Source DB: PubMed Journal: Bone Marrow Transplant ISSN： 0268-3369 Impact factor: 5.483

Keyword Cloud
Cited

× No keyword cloud information.

13 in total

1. Prophylactic Effect of Recombinant Human Soluble Thrombomodulin for Hepatic Sinusoidal Obstruction Syndrome Model Mice.

Authors: Shunsuke Kanou; Tomoharu Miyashita; Yasuhiko Yamamoto; Satoshi Takada; Makoto Nakura; Mitsuyoshi Okazaki; Yoshinao Ohbatake; Shinichi Nakanuma; Isamu Makino; Hidehiro Tajima; Hiroyuki Takamura; Sachio Fushida; Tetsuo Ohta
Journal: In Vivo Date: 2020 May-Jun Impact factor: 2.155

Review 2. Engraftment syndrome: double-edged sword of hematopoietic cell transplants.

Authors: T R Spitzer
Journal: Bone Marrow Transplant Date: 2015-01-12 Impact factor: 5.483

3. Thrombomodulin blocks calcineurin inhibitor-induced vascular permeability via inhibition of Src/VE-cadherin axis.

Authors: T Ikezoe; J Yang; C Nishioka; K Umezawa; A Yokoyama
Journal: Bone Marrow Transplant Date: 2016-09-19 Impact factor: 5.483

Review 4. Pathogenesis of disseminated intravascular coagulation in patients with acute promyelocytic leukemia, and its treatment using recombinant human soluble thrombomodulin.

Authors: Takayuki Ikezoe
Journal: Int J Hematol Date: 2013-11-12 Impact factor: 2.490

5. Sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation: Incidence, risk factors and outcomes.

Authors: K Yakushijin; Y Atsuta; N Doki; A Yokota; H Kanamori; T Miyamoto; C Ohwada; K Miyamura; Y Nawa; M Kurokawa; I Mizuno; T Mori; M Onizuka; J Taguchi; T Ichinohe; H Yabe; Y Morishima; K Kato; R Suzuki; T Fukuda
Journal: Bone Marrow Transplant Date: 2015-11-23 Impact factor: 5.483

6. Thrombomodulin alleviates murine GVHD in association with an increase in the proportion of regulatory T cells in the spleen.

Authors: T Ikezoe; J Yang; C Nishioka; A Yokoyama
Journal: Bone Marrow Transplant Date: 2014-09-22 Impact factor: 5.483

7. The fifth epidermal growth factor-like region of thrombomodulin exerts cytoprotective function and prevents SOS in a murine model.

Authors: T Ikezoe; J Yang; C Nishioka; B Pan; K Xu; M Furihata; K Nakamura; H Yurimoto; Y Sakai; G Honda; A Yokoyama
Journal: Bone Marrow Transplant Date: 2016-07-18 Impact factor: 5.483